Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for reduction of output in high-output enterocutaneous fistula or enterostomy
NL-OMON25162Recruiting
- Sponsor
- Academic Medical Center
- Start
- Feb 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of lanreotide in enterocutaneous fistula (ECF) and enterostomy (2 arms), sponsored by Academic Medical Center. Primary endpoint: Responders at week 8. Started Feb 2014; status: recruiting.
02
Drugs
lanreotide
03
Conditions
enterocutaneous fistula (ECF)enterostomy
Beyond the preview
Go deeper on NL-OMON25162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25162.